4 transcripts
RXST
Earnings call transcript
NASDAQ
2024 Q2
5 Aug 24
the benefits to whoever acquires the technology. And that's important because this is a -- we're entering into a long-term relationship with our customers
RXST
Earnings call transcript
NASDAQ
2024 Q1
6 May 24
. We believe that when patients understand the full benefits of adjustability, they are more likely to choose an LAL over a fixed lens alternative
RXST
Earnings call transcript
NASDAQ
2023 Q4
28 Feb 24
recognition of the clinical and economic benefits provided by the RxSight system and the adjustability of our LAL technology.In the fourth quarter
RXST
Earnings call transcript
NASDAQ
2023 Q2
7 Aug 23
margin from our reconfigured LDD, which we expect to begin shipping this year, with a gross margin benefit largely in the fourth quarter.
We
- Prev
- 1
- Next